Facebook
Instagram
Linkedin
Soundcloud
Twitter
Youtube
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Search
FDAReview.org
A PROJECT OF THE INDEPENDENT INSTITUTE
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Home
2018
Yearly Archives: 2018
Blog
Three Reasons To Be Optimistic about Pharmaceutical Policy
Raymond March
-
August 2, 2018
0
Blog
If Telemedicine Is Underachieving, Government Is to Blame
Raymond March
-
July 11, 2018
0
Blog
Misdiagnosing Right-to-try Laws
Raymond March
-
July 6, 2018
0
Blog
Putting Right-to-Try Drug Prices in Perspective
Raymond March
-
July 2, 2018
0
Blog
EpiPen Pricing Controversy Reveals Ignorance about Market Competition
Raymond March
-
June 22, 2018
0
Blog
FDA Moves Closer to Approving Ecstasy
Raymond March
-
June 19, 2018
0
Blog
Right-to-Try Law Signed!
Raymond March
-
June 18, 2018
0
Blog
Curing Diseases Is Sustainable, Government in Healthcare Is Not
Raymond March
-
May 3, 2018
0
Blog
FDA Issues First Mandatory Recall for Contaminated Food
Raymond March
-
April 25, 2018
0
Blog
FDA Restricts Sale of Contraceptive Device
Raymond March
-
April 18, 2018
0
1
2
3
Page 2 of 3
